Correlation between mutation landscape and clinical outcomes of neoadjuvant therapy in HER2-positive breast cancer patients.

Ning Liao,Yulei Wang,Kai Li,Bo Chen,Guochun Zhang,XueRui Li,Liping Guo,Li Cao,Chongyang Ren,Lingzhu Wen,Minghan Jia,Cheukfai Li,Hsiaopei Mok,Xiaoqing Chen,Guangnan Wei,Jiali Lin,Ting Hou,Han Han Zhang,Zhou Zhang,Jing Liu

Correlation between mutation landscape and clinical outcomes of neoadjuvant therapy in HER2-positive breast cancer patients.

2019

579Background: The standard management of early stage human epidermal growth factor receptor 2 (HER2) positive (+) breast cancer (BC) involves neoadjuvant therapy with combination of chemotherapy a...

Keywords:

Oncology
Pathology
HER2 Positive Breast Cancer
Correlation
Internal medicine
Neoadjuvant therapy
Medicine
Mutation
Human Epidermal Growth Factor Receptor 2
Breast cancer
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations